Skip to main content
OpenTrials
Completed

NCT Number: NCT06078241

Postoperative Analgesia in Patients Undergoing Percutaneous Nephrolithotomy

Percutaneous nephrolithotomy (PCNL) is a minimally invasive procedure to remove stones from the kidney by a small puncture wound through the skin. Patients receiving lidocaine infusion had lower pain scores, reduced postoperative analgesic requirements and decreased intraoperative anesthetic requirements. Erector spinae plane block (ESPB) seems to be effective when compared with no block or a placebo block.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Analgesia

Age range

21 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ain-Shams University Hospitals

Cairo, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • American Society of Anesthesiologists (ASA) score I-II..
  • Body mass index < 35 kg/m2.

Exclusion criteria

  • Patient's refusal.
  • Known coagulopathy.
  • Known peripheral neuropathy or neurological deficits.
  • Chronic pain disorders.
  • Known allergy to study drugs

Treatment and study plan

intravenous lidocaine infusion

Drug

Intravenous lidocaine infusion

Erector Spinae Plane Block (ESPB)

Other

Unilateral erector spinae plane block

Intravenous infusion of normal saline

Other

Intravenous infusion of normal saline

ESPB with normal saline

Other

Unilateral ESPB with normal saline

Primary outcomes

  1. Time to first rescue analgesia

    Time frame: 24 hours postoperatively

    Time to first rescue analgesia

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Intravenous Lidocaine Infusion Versus Ultrasound Guided Erector Spinae Plane Block for Postoperative Analgesia in Patients Undergoing Percutaneous Nephrolithotomy

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 11, 2023
Registry last updated
Nov 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.